Some benefits continue after estrogen-only therapy withdrawal

04/5/2011 | Los Angeles Times (tiered subscription model)

Data from the Women's Health Initiative indicate that four years after stopping estrogen-only therapy in women who had a hysterectomy, the increased risks of stroke and blood clots in the legs had dissipated. The reduced risk of breast cancer held steady, but the decreased risk of hip fracture seen while taking the estrogen-only therapy reverted to baseline four years after the intervention, according to the study in the Journal of the American Medical Association.

View Full Article in:

Los Angeles Times (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT